متلازمة تكيس المبايض وحصوات المسالك البولية: تحليل معدل حسب مؤشر كتلة الجسم لدى النساء العراقيات

Kaygusuz I, Karatas OF, Kafali H, Cimentepe E, Unal D. Is polycystic ovarian syndrome a risk factor for urolithiasis? Urolithiasis. 2013;41(4):361-362. doi: 10.1007/s00240-013-0564-9. DOI: https://doi.org/10.1007/s00240-013-0564-9

Adashi EY, Cibula D, Peterson M, Azziz R. The polycystic ovary syndrome: the first 150 years of study. F S Rep. 2022;4(1):2-18. doi: 10.1016/j.xfre.2022.12.002. DOI: https://doi.org/10.1016/j.xfre.2022.12.002

Singh S, Pal N, Shubham S, Sarma DK, Verma V, Marotta F, et al. Polycystic ovary syndrome: Etiology, current management, and future therapeutics. J Clin Med. 2023;12(4):1454. doi: 10.3390/jcm12041454. DOI: https://doi.org/10.3390/jcm12041454

Aziz ZN-E, Saleh BO, Thaker AZ. Free testosterone, dihydrotestosterone, and adiponectin in the evaluation of vitamin D supplementation for polycystic ovarian syndrome: A metformin comparative study. Al-Kindy Coll Med J. 2024;20(3):239-244. DOI: https://doi.org/10.47723/nb5he078

Abdull TN. Step-up protocol gonadotrophin versus laparoscopic ovarian drilling in clomiphene citrate resistant PCOS infertile women in two Iraqi hospitals. Al-Kindy Coll Med J. 2019;15(1):103-109. DOI: https://doi.org/10.47723/kcmj.v15i1.89

Bellver J, Rodríguez-Tabernero L, Robles A, Muñoz E, Martínez F, Landeras J, et al. Polycystic ovary syndrome throughout a woman's life. J Assist Reprod Genet. 2018;35(1):25-39. doi: 10.1007/s10815-017-1047-7. DOI: https://doi.org/10.1007/s10815-017-1047-7

Legro RS, Strauss JF. Molecular progress in infertility: polycystic ovary syndrome. Fertil Steril. 2002;78(3):569–576. doi: 10.1016/s0015-0282(02)03275-2. DOI: https://doi.org/10.1016/S0015-0282(02)03275-2

Rasquin LI, Anastasopoulou C, Mayrin JV. Polycystic ovarian disease. 2022 Nov 15. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. PMID: 29083730.

Azziz R. Polycystic ovary syndrome. Obstet Gynecol. 2018;132(2):321-336. doi: 10.1097/AOG.0000000000002698. DOI: https://doi.org/10.1097/AOG.0000000000002698

Rostami Dovom M, Rahmati M, Amanollahi Soudmand S, Ziaeefar P, Azizi F, Ramezani Tehrani F. The hidden link between polycystic ovary syndrome and kidney stones: Finding from the Tehran Lipid and Glucose Study (TLGS). Diagnostics (Basel). 2023;13(17):2814. doi: 10.3390/diagnostics13172814. DOI: https://doi.org/10.3390/diagnostics13172814

Tahir NL, Hassan QA, Kamber HM. The prevalence of a clinically silent nephrolithiasis in Baghdad population: An initial ultrasound screening study from Iraq. Acta Medica Iranica. 2019:51-56. doi: 10.18502/acta.v57i1.1753. DOI: https://doi.org/10.18502/acta.v57i1.1753

Almannie RM, Al-Nasser KA, Al-Barraq KM, Alsheheli MM, Al-Hazmi HH, Binsaleh SA, et al. The effect of the body mass index on the types of urinary tract stones. Urol Ann. 2020;12(1):42-48. doi: 10.4103/UA.UA_161_18. DOI: https://doi.org/10.4103/UA.UA_161_18

Mosli HA, Mosli HH. Increased body mass index is associated with larger renal calculi. Urology. 2012;80:974-977. doi: 10.1016/j.urology.2012.07.027. DOI: https://doi.org/10.1016/j.urology.2012.07.027

Del Valle EE, Negri AL, Spivacow FR, Rosende G, Forrester M, Pinduli I. Metabolic diagnosis in stone formers in relation to body mass index. Urol Res. 2012;40(1):47-52. doi: 10.1007/s00240-011-0392-8. DOI: https://doi.org/10.1007/s00240-011-0392-8

Puttabyatappa M, Padmanabhan V. Ovarian and extra-ovarian mediators in the development of polycystic ovary syndrome. J Mol Endocrinol. 2018;61(4):R161-R184. doi: 10.1530/JME-18-0079. DOI: https://doi.org/10.1530/JME-18-0079

Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41-47. doi: 10.1093/humrep/deh098. DOI: https://doi.org/10.1093/humrep/deh098

Skolarikos A, Jung H, Neisius A, Petřík A, Somani B, Tailly T, et al. EAU Guidelines on Urolithiasis 2024. European Association of Urology 2024. Available from: https://uroweb.org/guidelines/urolithiasis

Cohen J. Statistical power analysis for the behavioral sciences. Routledge; 2013. doi: 10.4324/9780203771587. DOI: https://doi.org/10.4324/9780203771587

Fedrigon D, Alazem K, Sivalingam S, Monga M, Calle J. Nephrolithiasis and polycystic ovary syndrome: A case-control study evaluating testosterone and urinary stone metabolic panels. Adv Urol. 2019;2019:3679493. doi: 10.1155/2019/3679493. DOI: https://doi.org/10.1155/2019/3679493

Zhu X, Kaygusuz I, Eser A, Yildirim ME, Çimentepe E, Yüce E, et al. Is polycystic ovarian syndrome a risk factor for urinary stone disease? Clin Oncol. 2018;3:1443.

Jalilian N, Haghnazari L, Rasolinia S. Leptin and body mass index in polycystic ovary syndrome. Indian J Endocrinol Metab. 2016;20(3):324-328. doi: 10.4103/2230-8210.180005. DOI: https://doi.org/10.4103/2230-8210.180005

Fang Y, Liu L, Yang Y, Zhang B, Xie S. Causal association between BMI and polycystic ovarian syndrome: Bidirectional 2-sample mendelian randomization study. J Clin Endocrinol Metab. 2024;110(1):41-47. doi: 10.1210/clinem/dgae446. DOI: https://doi.org/10.1210/clinem/dgae446

Feng X, Wu W, Zhao F, Xu F, Han D, Guo X, et al. Relationship between body mass index and kidney stones based on dose-response analyses using restricted cubic splines applied to NHANES 2011-2016 data. J Ren Nutr. 2021;31(3):263-269. doi: 10.1053/j.jrn.2020.05.003. DOI: https://doi.org/10.1053/j.jrn.2020.05.003

Güler Y. Effects of body mass index on urinary lithogenic factors in urinary system stone patients. Folia Med (Plovdiv). 2024;66(1):80-87. doi: 10.3897/folmed.66.e114369. DOI: https://doi.org/10.3897/folmed.66.e114369